AnaptysBio

Reporting live from #ACR24 in D.C.! We’ve had a wonderful week exploring new ideas with fellow leading innovators and sharing updates on our ongoing #ClinicalResearch in #RheumatoidArthritis and #UlcerativeColitis. #ACRConvergence #WeAreAnaptysBio

We are thrilled to be in Washington, D.C. for the annual American College of Rheumatology Convergence meeting! Check out poster info below and visit our website to learn about our work to advance the development of therapeutic antibodies with the potential to modulate the inflammatory response and restore healthy immune function. www.anaptysbio.com #ACR24 #ACRConvergence

#NEWS:?BioSpace?has recognized Anaptys as a Best Place to Work for the third year in a row! This outstanding achievement is a reflection of the passion and dedication of our team to our shared vision to transform patient health by delivering innovative immunology therapeutics. Guided by our core values of accountability, transparency and humility, we'll continue to strive to achieve "Best Place to Work" honors year over year. ?? #WeAreAnaptysBio #CompanyCulture #BiopharmaLeaders #InnovationInMedicine

Dr. Martin Dahl, SVP of Research, was drawn to #Immunology because of the opportunity to impact many different #Inflammatory and #AutoimmuneDiseases. Recently, he put pen to paper and shared some key considerations to keep in mind when developing therapeutic antibodies to modify these diseases. Read the article at Drug Discovery Online: https://bit.ly/3Y5TsD0

We recently announced enrollment completion of the Phase 2b RENOIR Study evaluating our investigational PD-1 agonist rosnilimab in #RheumatoidArthritis (RA). This milestone achievement would not be possible without the support of the physicians, researchers, #ClinicalTrial participants and advocates who believe in the possibility of better treatments for patients living with RA. $ANAB #ClinicalTrialEnrollment

Today, we announced our #Q3 financial earnings and provided an update on our work to transform patient health by delivering innovative #ImmunologyTherapeutics.? ? Read our full announcement: https://bit.ly/3UDoIZl ?? #Q3Earnings $ANAB?

We didn’t just dress up ??, we made a difference! This month, we celebrated our third annual Halloween Party Auction by raising funds for Life Science Cares San Diego. Thanks to our team members who donated and joined us for a frightfully fun time! #WeAreAnaptysBio

In honor of Eczema Awareness Month, we recently hosted a special fireside chat with Andrea, a young woman living with eczema. ? Andrea’s story is an important reminder of the resilience of the global eczema community and the ongoing work needed to support people living with this condition. We thank Andrea and all patient ambassadors like her for their time and work to raise awareness! ? #WeAreAnaptysBio

New faces, new energy! We recently welcomed three exceptional new colleagues to Team Anaptys. We’re so glad you’re here, George Migias, Min Bao and Veronica Gutierrez Banegas! #WeAreAnaptysBio #NewHires #CompanyCulture

Curious to learn about our ongoing research and work to develop new medicines for #Autoimmune and #InflammatoryDiseases? Make sure to check out "Short Takes on Deep Science,” our education hub with expert perspectives that you can trust – no Ph.D. required!? ? Listen now: https://lnkd.in/eVM7G9DQ?